To investigate the effect of hydrogen sulfide (H2S) on myocardial injury in sepsis-induced myocardial dysfunction (SIMD), male C57BL/6 mice were intraperitoneally injected with lipopolysaccharide (LPS) (10 mg/kg, i.p.) to induce cardiac dysfunction without or with the H2S donor sodium hydrosulfide (NaHS) (50 µmol/kg, i.p.) administration 3 h after LPS injection. Six hours after the LPS injection, echocardiography, cardiac hematoxylin and eosin (HE) staining, myocardial damage and inflammatory biomarkers and Western blot results were analyzed. In mice, the administration of LPS decreased left ventricular ejection fraction (LVEF) by 30 % along with lowered H2S levels (35 % reduction). It was observed that cardiac troponin I (cTnI), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta) levels were all increased (by 0.22-fold, 2000-fold and 0.66-fold respectively). HE staining revealed structural damage and inflammatory cell infiltration in the myocardial tissue after LPS administration. Moreover, after 6 h of LPS treatment, toll-like receptor 4 (TLR4) and nod-like receptor protein 3 (NLRP3) expressions were up-regulated 2.7-fold and 1.6-fold respectively. When compared to the septic mice, NaHS enhanced ventricular function (by 0.19-fold), decreased cTnI, TNF-alpha, and IL-1beta levels (by 11 %, 33 %, and 16 % respectively) and downregulated TLR4 and NLRP3 expressions (by 64 % and 31 % respectively). Furthermore, NaHS did not further improve cardiac function and inflammation in TLR4-/- mice or mice in which NLRP3 activation was inhibited by MCC950, after LPS injection. In conclusion, these findings imply that decreased endogenous H2S promotes the progression of SIMD, whereas exogenous H2S alleviates SIMD by inhibiting inflammation via the TLR4-NLRP3 pathway suppression.

Department of Physiology Hebei Medical University Hebei China

Zobrazit více v PubMed

Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75–87. doi: 10.1016/S0140-6736(18)30696-2. PubMed DOI

Yang H, Zhang Z. Sepsis-induced myocardial dysfunction: the role of mitochondrial dysfunction. Inflamm Res. 2021;70:379–387. doi: 10.1007/s00011-021-01447-0. PubMed DOI

Chen J, Wang B, Lai J, Braunstein Z, He M, Ruan G, Yin Z, et al. Trimetazidine attenuates cardiac dysfunction in endotoxemia and sepsis by promoting neutrophil migration. Front Immunol. 2018;9:2015. doi: 10.3389/fimmu.2018.02015. PubMed DOI PMC

Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021;18:424–434. doi: 10.1038/s41569-020-00492-2. PubMed DOI

Huang YQ, Jin HF, Zhang H, Tang CS, Du JB. Interaction among hydrogen sulfide and other gasotransmitters in mammalian physiology and pathophysiology. Adv Exp Med Biol. 2021;1315:205–236. doi: 10.1007/978-981-16-0991-6_9. PubMed DOI

Kimura H. Hydrogen sulfide (H2S) and polysulfide (H2Sn) signaling: The first 25 years. Biomolecules. 2021;11:896. doi: 10.3390/biom11060896. PubMed DOI PMC

Sun HJ, Wu ZY, Nie XW, Bian JS. Role of endothelial dysfunction in cardiovascular diseases: The link between inflammation and hydrogen sulfide. Front Pharmacol. 2020;10:1568. doi: 10.3389/fphar.2019.01568. PubMed DOI PMC

Wen YD, Wang H, Zhu YZ. The drug developments of hydrogen sulfide on cardiovascular disease. Oxid Med Cell Longev. 2018;2018:4010395. doi: 10.1155/2018/4010395. PubMed DOI PMC

Chen YH, Teng X, Hu ZJ, Tian DY, Jin S, Wu YM. Hydrogen sulfide attenuated sepsis-induced myocardial dysfunction through TLR4 pathway and endoplasmic reticulum stress. Front Physiol. 2021;12:653601. doi: 10.3389/fphys.2021.653601. PubMed DOI PMC

Huang Z, Zhuang X, Xie C, Hu X, Dong X, Guo Y, Li S, Liao X. Exogenous hydrogen sulfide attenuates high glucose-induced cardiotoxicity by inhibiting NLRP3 inflammasome activation by suppressing TLR4/NF-κB pathway in H9c2 cells. Cell Physiol Biochem. 2016;40:1578–1590. doi: 10.1159/000453208. PubMed DOI

Li J, Ma J, Li M, Tao J, Chen J, Yao C, Yao S. GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRβ/Akt/NF-κB/NLRP3 pathway. Life Sci. 2021;271:119192. doi: 10.1016/j.lfs.2021.119192. PubMed DOI

Wang L, Hauenstein AV. The NLRP3 inflammasome: Mechanism of action, role in disease and therapies. Mol Aspects Med. 2020;76:100889. doi: 10.1016/j.mam.2020.100889. PubMed DOI

Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10:128. doi: 10.1038/s41419-019-1413-8. PubMed DOI PMC

Dai Y, Wang S, Chang S, Ren D, Shali S, Li C, Yang H, Huang Z, Ge J. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway. J Mol Cell Cardiol. 2020;142:65–79. doi: 10.1016/j.yjmcc.2020.02.007. PubMed DOI

Toldo S, Mauro AG, Cutter Z, Abbate A. Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2018;315:H1553–H1568. doi: 10.1152/ajpheart.00158.2018. PubMed DOI PMC

Xue J, Ge H, Lin Z, Wang H, Lin W, Liu Y, Wu G, Xia J, Zhao Q. The role of dendritic cells regulated by HMGB1/TLR4 signalling pathway in myocardial ischaemia reperfusion injury. J Cell Mol Med. 2019;23:2849–2862. doi: 10.1111/jcmm.14192. PubMed DOI PMC

Li S, Guo Z, Zhang ZY. Protective effects of NLRP3 inhibitor MCC950 on sepsis-induced myocardial dysfunction. J Biol Regul Homeost Agents. 2021;35:141–150. doi: 10.23812/20-662-A. PubMed DOI

Andelova K, Egan Benova T, Szeiffova Bacova B, Sykora M, Prado NJ, Diez ER, Hlivak P, Tribulova N. Cardiac connexin-43 hemichannels and pannexin1 channels: Provocative antiarrhythmic targets. Int J Mol Sci. 2020;22:260. doi: 10.3390/ijms22010260. PubMed DOI PMC

Ni X, Zhang L, Peng M, Shen TW, Yu XS, Shan LY, Li L, Si JQ, Li XZ, Ma KT. Hydrogen sulfide attenuates hypertensive inflammation via regulating connexin expression in spontaneously hypertensive rats. Med Sci Monit. 2018;24:1205–1218. doi: 10.12659/MSM.908761. PubMed DOI PMC

Rello J, Valenzuela-Sánchez F, Ruiz-Rodriguez M, Moyano S. Sepsis: A review of advances in management. Ad Ther. 2017;34:2393–2411. doi: 10.1007/s12325-017-0622-8. PubMed DOI PMC

Ehrman RR, Sullivan AN, Favot MJ, Sherwin RL, Reynolds CA, Abidov A, Levy PD. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature. Crit Care. 2018;22:112. doi: 10.1186/s13054-018-2043-8. PubMed DOI PMC

Fattahi F, Ward PA. Complement and sepsis-induced heart dysfunction. Mol Immunol. 2017;84:57–64. doi: 10.1016/j.molimm.2016.11.012. PubMed DOI PMC

Lv X, Wang H. Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res. 2016;3:30. doi: 10.1186/s40779-016-0099-9. PubMed DOI PMC

Hajishengallis G, Lambris JD. More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol Rev. 2016;274:233–244. doi: 10.1111/imr.12467. PubMed DOI PMC

Zou L, Feng Y, Chen YJ, Si R, Shen S, Zhou Q, Ichinose F, Scherrer-Crosbie M, Chao W. Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis. Crit Care Med. 2010;38:1335–1342. doi: 10.1097/CCM.0b013e3181d99e67. PubMed DOI PMC

Lin Y, Xu Y, Zhang Z. Sepsis-induced myocardial dysfunction (SIMD): The pathophysiological mechanisms and therapeutic strategies targeting mitochondria. Inflammation. 2020;43:1184–1200. doi: 10.1007/s10753-020-01233-w. PubMed DOI

Tsolaki V, Makris D, Mantzarlis K, Zakynthinos E. Sepsis-induced cardiomyopathy: Oxidative implications in the initiation and resolution of the damage. Oxid Med Cell Longev. 2017;2017:7393525. doi: 10.1155/2017/7393525. PubMed DOI PMC

Zaorska E, Tomasova L, Koszelewski D, Ostaszewski R, Ufnal M. Hydrogen sulfide in pharmacotherapy, beyond the hydrogen sulfide-donors. Biomolecules. 2020;10:323. doi: 10.3390/biom10020323. PubMed DOI PMC

Liu J, Li J, Tian P, Guli B, Weng G, Li L, Cheng Q. H2S attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism. Exp Ther Med. 2019;17:4064–4072. doi: 10.3892/etm.2019.7440. PubMed DOI PMC

Pan LL, Liu XH, Gong QH, Zhu YZ. S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism. Amino Acids. 2011;41:205–215. doi: 10.1007/s00726-011-0834-1. PubMed DOI

Liu S, Wang X, Pan L, Wu W, Yang D, Qin M, Jia W, Xiao C, Long F, Ge J, Liu X, Zhu Y. Endogenous hydrogen sulfide regulates histone demethylase JMJD3-mediated inflammatory response in LPS-stimulated macrophages and in a mouse model of LPS-induced septic shock. Biochem Pharmacol. 2018;149:153–162. doi: 10.1016/j.bcp.2017.10.010. PubMed DOI

Zimmermann KK, Spassov SG, Strosing KM, Ihle PM, Engelstaedter H, Hoetzel A, Faller S. Hydrogen sulfide exerts anti-oxidative and anti-inflammatory effects in acute lung injury. Inflammation. 2018;41:249–259. doi: 10.1007/s10753-017-0684-4. PubMed DOI

Qiu Z, Lei S, Zhao B, Wu Y, Su W, Liu M, Meng Q, Zhou B, Leng Y, Xia ZY. NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats. Oxid Med Cell Longev. 2017;2017:9743280. doi: 10.1155/2017/9743280. PubMed DOI PMC

Guo T, Jiang ZB, Tong ZY, Zhou Y, Chai XP, Xiao XZ. Shikonin ameliorates LPS-induced cardiac dysfunction by SIRT1-dependent inhibition of NLRP3 inflammasome. Front Physiol. 2020;11:570441. doi: 10.3389/fphys.2020.570441. PubMed DOI PMC

Cacanyiova S, Berenyiova A, Kristek F. The role of hydrogen sulphide in blood pressure regulation. Physiol Res. 2016;65(Suppl 3):S273–S289. doi: 10.33549/physiolres.933438. PubMed DOI

Košir M, Podbregar M. Advances in the diagnosis of sepsis: hydrogen sulfide as a prognostic marker of septic shock severity. EJIFCC. 2017;28:134–141. PubMed PMC

Li L, Salto-Tellez M, Tan CH, Whiteman M, Moore PK. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic Biol Med. 2009;47:103–113. doi: 10.1016/j.freeradbiomed.2009.04.014. PubMed DOI

ST-Segment Alterations in the Electrocardiogram of Acute Pulmonary Thromboembolism: A Rabbit Model